| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.7M | +9.2% |
| Cost of Revenue | $362K | +19.3% |
| Gross Profit | $2.3M | +7.8% |
| R&D Expense | $206K | +21.7% |
| SG&A Expense | $8.9M | +7.5% |
| Operating Income | -$7.2M | -7.4% |
| Interest Expense | $174K | -63.4% |
| Net Income | -$8.2M | +43.7% |
| EPS (Basic) | -$1.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | +4605.8% |
| Accounts Receivable | $245K | +234.3% |
| Inventory | $44K | +108.9% |
| Current Assets | $4.3M | +1658.5% |
| Total Assets | $4.8M | +833.8% |
| Current Liabilities | $2.4M | +29.0% |
| Total Liabilities | $2.7M | +40.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +8.9% |
| Capital Expenditures | $28K | -9.8% |
| Investing Cash Flow | -$28K | +61.3% |
| Financing Cash Flow | $9.7M | +47.9% |
| Free Cash Flow | -$6.1M | +8.9% |
| +72.9% |
| EPS (Diluted) | -$1.22 | +72.9% |
| Stockholders' Equity |
| $2.1M |
| +247.4% |